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Background. Efficient islet isolation represents a necessary requirement for successful islet transplantation as a treat-
ment for type 1 diabetes. The choice of collagenase for pancreas digestion is critical for the isolation outcome, and
Liberase™ is the most widely used enzyme, although large intra-batched variability in activity and efficiency has been
observed.
Methods.The aim of this study was to characterize Liberase™ components and their relative role in pancreas digestion.
Liberase batches were characterized by microelectrophoresis.
Results. By means of microelectrophoresis, we identified three main proteins each with different prevalences between
batches. Two proteins were found to correspond to class I (CI) and one to class II (CII) collagenase. In a series of 163
islet isolations, we observed that the CII correlated with islet yield (P0.001) and digestion time (P0.001); addition-
ally, CI directly correlated with purity (P0.028). Finally, when CII and one of the CI isoforms were50 percentile, 15
of 36 preparations were transplanted, with 27 of 127 transplanted in the other cases (P0.013).
Conclusion. These results represent an important step toward the characterization of enzymes, with the final aim of
identifying key components for a standardized product.
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A standardization of human islet isolation that produces asufficient number of good-quality islets in a reproduc-
ible way is an essential requisite for a successful clinical trans-
plant program (1). An optimization of isolation techniques
would permit an increased number of transplants and a re-
duction of costs, which are important requisites for securing
reimbursement for this procedure from health insurance
providers and national health systems.
To date, a real standardized procedure has not been
possible because of the fact that one of the crucial steps of
isolation, organ digestion, does not yield a standardized
product. Second, the enzyme used, collagenase, presents dif-
ferent characteristics from batch to batch, and from vial to
vial, because of problems of instability (2, 3). Furthermore,
there are no precise parameters for the evaluation of enzy-
matic efficacy before its use; therefore, it is necessary to
experiment with an enzyme batch many times before deter-
mining its suitability. Enzyme activity per se, commonly
available for each batch, is not considered a useful param-
eter for the selection of successful batches and therefore
other parameters or methods of analyses are expected at
this purpose (4).
The introduction of purified products has not solved
that problem (5–6), because the proposed enzymes are al-
ways obtained from Clostridium histolyticum cultures and
remain different from batch to batch as well. A significant
variability of enzyme activity was recently described not only
between Liberase batches but also between vials of the same
batch (3). The first experiments with a type of recombinant
collagenase have not provided additional information (7). In
fact, with the data now available, standardization remains a
difficult challenge, because the composition of efficient en-
zyme blends, especially for human pancreas digestion, is not
yet well defined (8).
Different isoforms of collagenase, identified by the
Greek letters (, , , , , ), belong to two classes (CI and
CII) (9–12). Concerning the rat pancreas digestion, it has
been reported that the CII is the most efficient at digesting
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exocrine tissue, whereas CI increases the digestion rate (13,
14); therefore, an appropriate mix of CI and CII has been
proposed to optimize islet isolation (15–18). In the early
stages of digestion, neutral proteases also are needed, but in
excessive amounts these can destroy islet integrity (19–21). A
protocol for using CI and CII together with neutral proteases
for the human pancreas digestion has been proposed (22),
but nothing is known about the role of the different isoforms
of collagenase within the same class.
MATERIALS ANDMETHODS
Islet Isolation
Islets were isolated using the automated method de-
scribed by Ricordi (23) and purified as previously described
(24). The enzyme used for isolation was Liberase™ (0.5–1.4
mg/mL; Roche, Indianapolis, IN). In 350 mL of Hank’s solu-
tion, an amount of enzymes ranging from 175 to 500 mg
(related to the trimmed pancreas weight, about 4 mg of en-
zyme per gramof pancreas) was gentle dissolved. The enzyme
concentration was further reduced (up to 50%) if the donor
was younger than 20 years old. All preparations were submit-
ted to the purification (for transplantation or for research
purpose) with the exception of those in which digestion com-
pletely failed (completely destroyed islets or undigested tis-
sue). In these cases, the number of isolated islets was reported
to be 0, as well as in those isolations in which the purification
completely failed and all the tissue was discharged. The final
number of isolated islets considered in the analyses and their
corresponding purity were calculated, including all gradient
layers with islets up to remaining under 10 mL of total tissue
volume (as in the case of a possible islet transplantation). Islet
cell viability was estimated by propidium iodide staining and
insulin responsiveness to glucose by static incubation, as pre-
viously described (4).
Bacterial Collagenases
Liberase™ HI (15 batches) from C. histolyticum used
in human isolation were analyzed. The different sample
batches were collected during a period of 3 years. Each
aliquot of Liberase™ was collected before enzyme recon-
stitution from a new vial, after proper equilibration on ice
and mixing of the vial contents (3). Four samples were re-
constituted from each batch with 10 mM EDTA solution
(Sigma-Aldrich Corporation, S. Louis, MO) on ice and
quickly loaded for characterization using different analyses. A
protocol for the preparation of enzyme samples was tested
and standardized to prevent uncontrolled degradation prior
to biochemical analysis and to be used in isolations. The sam-
ples’ final concentrationwas 1mg/ml for the Protein 200 Plus
Assay (Agilent Technologies, Palo Alto, CA; milligram of
powder mass provided by the manufacture).
The samples from lyophilized separated components,
Collagenase Class I, Collagenase Class II, and Thermolysin
(Roche, Indianapolis, IN), were similarly collected and re-
constituted. Activity is expressed in Wunsch units (U/mg or
U/vial) for collagenase class II and Liberase, in Caseinase
units (U/mg or U/vial) for neutral proteases. These values
were obtained from the Roche’s Certificate of Analysis.
Microelectrophoresis Analysis
The Protein 200 Plus assay (Agilent Technologies, Palo
Alto, CA) allows sizing of proteins ranging from 14 to 200
kDa. Sensitivity of Protein 200 Plus assay is 20 ng/l bovine
serum albumin (BSA) in phosphate-buffered solution (PBS).
The chip-based separations were performed on the Agilent
2100 Bioanalyzer in combination with the Protein 200 Lab-
Chip kit and the dedicated Protein 200 assay software (Agi-
lent Technologies, Palo Alto, CA); each sample was double
loaded. Data are displayed as electropherogram or gel-like
image; a table with information regarding peaks (migration
time, molecular weight, peak area, % total) is generated for
each sample. The three main peaks were defined G, D, and B.
The proportion of the peak area of a specific collagenase frac-
tion relative to the sum of all peaks was expressed as a ratio,
and reported as an “Index” (3). To evaluate the intra-assay
coefficient of variations (%CV), samples from the same vial
were analyzed on the same microchip. The CV values were
2.6%, 5.1%, and 1.7% for peaks G, D, and B respectively. To
FIGURE 1. Liberase analyses by microelectrophoresis.
(a) Liberase™ profiles in analysis by microelectrophoresis
of two different batches (93017120, 93047420). Peak B and
peak G are inversely correlated (b).
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evaluate differences between vials of the same batch, samples
fromdifferent vials were tested on the samemicrochip (intra-
lot %CV). The CV values were 2.4%, 0.7%, and 5.3% for
peaks G, D, and B, respectively. Samples from different vials
of the same lot were analyzed using different microchips at
different times: 6.6%, 6.7%, 5.5% were the CV values
founded for peaks G, D, and B respectively.
Islet Transplantation
Transplantation was performed between 2 and 72 hr
after isolation. Preparations were considered adequate for
transplantation according to the following criteria: (1) NE
(5,000 per kg body weight); (2) purity 20% (dithizone-
staining determination of islet/total mass); and (3) islet ste-
rility and cell viability 70% analyzed by propidium iodide
(4). Purification was defined to be 20% or greater because, in
our experience, this limit maintains the tissue volume for
transplant to less than 10 mL. A total of 42 islet preparations
were transplanted into HLA-mismatched recipients affected
by type 1 diabetes as previously described (4). Recipients
gave informed consent and our investigations were ap-
proved by the responsible ethics committee (institutional re-
view board). Studies were conducted in accordance with the
Declaration of Helsinki as revised in 2000 (http://www.wma.
net/e/policy/b3.htm).
Statistical Analysis
Data were collected from 163 performed with Liberase™.
Isolations were not consecutive: procedures using collagenase
type P were excluded from the analyses.
Parameters to qualify Liberase components were as
follows:
• Isolation outcomes in terms of the total number of islets
expressed as finalNE (the absolute number corrected for
coefficients based on islet volume), digestion time and
purity. Final NE was preferred to prepurification NE.
The purification method in this panel of isolations was
the same and considering final NE instead of prepurifi-
cation, we included the possible interference of enzyme
also on purification.
• Islet cell viability (as percentage of live cells after pro-
pidium iodide staining) and insulin responsiveness to
glucose, as secretion index (the ratio between basal and
stimulated insulin secretion) as previously described (4).
• Decision whether or not to transplant the prepara-
tion. Islet preparation is defined suitable for the trans-
plant not only on the basis of the islet number, but
also on cell viability and purity (4). Therefore, this
represents an overall and indirect parameter of islet
preparation quality.
• Transplantation outcome in terms of posttransplant c-
peptide levels and exogenous insulin requirement 1 week
and 1 month after transplantation. Our recipients often
received 2 or more preparations simultaneously or in
subsequent transplantation. Also, immunosuppressive
treatment should vary in different patients. Therefore,
the number of transplants available for this analysis (sin-
gle islet preparation transplantation) was limited to 10
patients, with at least 1 month follow-up and similar
immunosuppressive treatment (Edmonton protocol, 4).
Variables did not show a Gaussian distribution, and a
nonparametric analysis was performed.Where both variables
were ordinal values, correlations were performed using the
Spearman rank correlation test and expressed as Spearman’s
correlation coefficient. All comparisons are 2 tailed. When
variables were nominal values, a 2-square test was used
and a P value lower than 0.05 was considered to be statis-
tically significant.
TABLE 1. Characteristics of different Liberase™ batches and prevalences of each peak
Liberase™
batches
Activity
(U/mg)
Neutral
protease (U/mg)
Peak p
index
Peak G
index
Peak D
index
Peak B
index
Remnant
index
93047420 4.248 155.6 0.013 0.466 0.292 0.173 0.056
90287220 4.922 193.2 0.022 0.109 0.287 0.459 0.123
93017120 4.170 147.2 0.016 0.194 0.286 0.426 0.078
93114320 4.216 120.7 0.018 0.230 0.284 0.378 0.090
93126020 4.048 120.4 0.026 0.184 0.354 0.420 0.016
93145320 4.454 133.8 0.026 0.357 0.306 0.213 0.098
93152720 4.970 132.1 0.024 0.296 0.310 0.340 0.030
93028820 4.404 146.9 0.017 0.152 0.317 0.458 0.056
93045820 3.900 140.3 0.029 0.416 0.282 0.180 0.093
93142020 4.794 147.6 0.024 0.331 0.286 0.260 0.099
93167720 5.058 142.4 —a 0.224 0.354 0.373 0.049
93163920 4.402 128.4 0.019 0.268 0.311 0.335 0.067
93187520 4.226 135.2 0.027 0.223 0.336 0.336 0.078
93172920 4.144 140.2 0.019 0.236 0.341 0.342 0.062
93273520 4.996 137.6 0.017 0.410 0.294 0.219 0.060
Activity is expressed in Wunsch units (U/mg) and neutral proteases in Caseinase units (U/mg). The prevalence of the peak area of a specific collagenase
fraction, relative to the sum of all peaks, was expressed as a ratio and reported as “Index.”
a This batch did not contained neutral protease.
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RESULTS
Analysis of Protein Content in Liberase™
Batches by Electrophoresis
Enzyme blends were first studied by microelectro-
phoresis. Unexpectedly, differently from that reported by the
Roche data sheet for Liberase™, and similarly to that previ-
ously reported by Lakey (3), more than two peaks appeared
from the analyses of batches. All Liberase™ batches showed
threemain peaks (G, D, B) and oneminor one (p) (see Fig. 1a
for the profile of two representative batches of those included
in the study). The molecular weight of peaks p, G, D, and B
were 341, 1151, 1271, and 1311 kDa, respectively
(values expressed as the mean of different batchesstandard
deviation). The absolute values of peaks depended strictly on
the amount of enzyme weighed, which might be subjected to
slight variations between different experiments. Therefore,
each peak was expressed as an Index (see Material andMeth-
ods section). Other small peaks (usually lower than 5%) ir-
regularly present in different batches, were considered as
“remnants.” Index values of remnants are inversely corre-
lated with CII index values (P0.001, r0.656). Liberase™
batches differ in terms of proportion of each peak (Table 1).
Peak B and peak G significantly and inversely correlate
(P0.001, r0.991, Fig. 1b), suggesting that the smaller
protein (peak G) could be derived from the larger one (peak B).
To identify themain peaks, we also performed amicro-
electrophoresis on the separate fractions produced by Roche.
In Figure 2a–c, the profiles of the separated components Col-
lagenase Class I (CI), Collagenase Class II (CII), and neutral
protease (Thermolysin) are shown and compared with a Lib-
erase™ profile. CII enzyme was overlapping with peak D
(molecular weight 1282 kDa, Fig. 2a), CI with peak B (mo-
lecular weight 1311 kDa), and G (1151 kDa; Fig. 2b).
Other small peaks with molecular weight 34 kDa, irregu-
larly present in different batches (10 of 15 batches, remnants),
were present only in vials containingCII collagenase (Fig. 2a).
Thermolysin profile showed few small peaks; that with the
greatest proportion value (molecular weight 341) was over-
lapping with peak p (Fig. 2c).
Correlation Between Peaks and Isolation
Outcome
The number of samples was insufficient to allow a di-
rect comparison among characteristics and results achieved
using different Liberase lots (see Table 2). Therefore values of
CI, CII, remnants, and protease peaks of different Liberase™
batches were pooled together and correlated with some rep-
resentative parameters of isolation outcome: NE, digestion
time, purity.
In these analysis NE directly and significantly corre-
latedwithCII (P0.001, r0.305, Fig. 3a) and inversely, near
to the significance, with remnants (P0.090, r0.133). Di-
gestion time inversely correlated with CII (significance
P0.001, r0.502) and directly with remnants (P0.001,
r0.266). The purity of preparations inversely and signifi-
cantly correlatedwith CI (peakG) (P0.024, r0.265) and
directly with CI (peak B) (P0.028, r0.260, Fig. 3b). No
correlations were observed between protease peak values and
isolation outcome (data not shown). As previously reported
(4) there is a large dispersion of the data (and therefore a low
“r” value) and this was expected according to the evidence
that many variables are affecting human islet isolation yield.
Because of the limited number of cases (n163) and to the
large number of variables affecting islet isolation (n32 in
our previous study, plus these new 4 variables) we were un-
FIGURE 2. Characterization of Liberase components.
(a–c) reported data achieved by microelectrophoresis
technique. An example of peak profile of a Liberase™
batch was represented by dotted line. (a) The Liberase™
profile was superimposed with that of class II enzyme (CII,
solid line) showing that CII correspond to peak D and to
“remnants.” (b) The Liberase™ profile was superimposed
with that of class I enzyme (CI, solid line) showing that CI
corresponded to peak G and B. (c) The Liberase™ profile
was superimposed to Thermolysin (solid line) showing that
thermolysin correspond to peak p.
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able to apply a propermultivariate analysis on these data. In a
previous multivariate analysis on more than 400 isolations,
we found that the activity/mg of collagenase corrected for the
total mg of enzyme used in each isolation (total activity)
strictly correlatedwith the number of isolated islets (4). In the
present study we found that when CII is similarly corrected
for the mg used in each isolation, it strictly correlates with
total activity (P0.001, r0.796).
We previously proposed as threshold to define the suc-
cess of islet isolation a procedure able to achieve islet yield
250,000 (equivalent islet) and with 20% of purity (4).
Accordingly, isolations were divided in two groups: success-
ful and unsuccessful. A significant difference was observed
between CII values of enzymes used in successful and unsuc-
cessful islet isolation (P0.006, Fig. 3c). The results of statis-
tical analyses did not change if only batches used more than
three times were included in the study.
We observed no statistical correlations between CI or
CII peak values and islet cell viability or insulin responsive-
ness to glucose (data not shown). However, the value of these
statistical analyses was probably insufficient due to the poor
number of cases available compare to the large dispersion of
the data observed.
Predictive Role of Collagenase Fractions Versus
Transplantation
High number of isolated islets, together with good islet
purity and quality, are taken into account in order to define
an islet preparation’s suitability for transplantation. We ver-
ified the association of each component of Liberase™with the
decision as to whether or not to transplant a preparation. In
isolations using a CII peak value	50 percentile, 33 out of 98
were transplanted, and when values were50 percentile, 9 of
65 were transplanted (2-test, P0.005). Considering that
the purity of preparations, together with NE, is a prerequisite
for islet transplantation, an additional criterion was intro-
duced due to the suggested positive role of CI peak B on
purification. In isolation using CII peak value	50 percentile
and CI peak B value	50 percentile, 15 out of 36 were trans-
planted and in the remaining cases, 27 out of 127 were trans-
planted (2-test, P0.013).
FromFigure 4, it appears evident that the highest values
of CII and CI peak B correspond neither to the highest islet
yield nor to the highest number of the transplanted islet prep-
arations. Accordingly if CII peak index is limited to 0.294–
0.315 and CI peak B to 0.20–0.35. (and as a consequence, the
remaining enzyme, CI peak G in the range of 0.25–0.40), 13
out 22 islet preparations were transplanted vs. 29 of 141 islet
preparations in the other cases (P0.001).
In recipients receiving islet transplantation c-peptide
values 1 week after transplantation correlated with CII peak
values (P0.041, r0.652, n10) and NE (P0.003,
r0.830, n10). No relationships were observed between CI
peak B or peakG values with oneweek graft function.No corre-
lation was found one month after transplantation between in
vivo islet graft and Liberase peak values (data not shown).
DISCUSSION
The available information concerning the characteris-
tics and composition of collagenase batches that are effective
in the digestion of human pancreas for islet transplants is
scarce and incomplete. Data achieved in animal model of
pancreas digestion should not applied without criticisms in
human pancreas where the clinical condition of the donors
and therefore of pancreas heavily interferewith digestion suc-
cess rate. In this work, we evaluated the components of Lib-
erase™ blend enzyme and their functional role in digestion of
human pancreas. This information represents the real basis
for a further standardization of the procedures. The issue of
standardization of the procedures is not only technical. The
discontinuity of isolation success is one of themost important
factors that limit the clinical applicability of islet transplanta-
tion.Discontinuous isolation resultsmeans in fact unpredict-
able costs of procedures and high variability of islet quality
and, finally, the impossibility to perform large studies aimed
at improving graft function.
TABLE 2. Isolation outcome according to different Liberase batches
Liberase™ batches Number of cases Equivalent islet numberSD Purity indexSD Digestion timeSD (min)
93047420 45 172932113972 0.40.2 216
90287220 24 149482131464 0.60.2 254
93017120 10 8585790580 0.50.3 236
93114320 15 177440108760 0.40.1 228
93126020 4 27225073477 0.50.1 225
93145320 1 396000 0.5 24
93152720 2 6750095459 0.30.4 19
93028820 1 150000 0.6 17
93045820 15 13088576700 0.40.2 256
93142020 2 96600136613 0.40.6 2810
93167720 8 22869494309 0.60.1 165
93163920 18 27964984516 0.60.1 123
93187520 1 25000 0.4 27
93172920 1 0 Not assessable 10
93273520 15 178287112772 0.70.02 154
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We observed that collagenase class II was shown to be
the most important enzyme for successful islet yield, thus
confirming in human pancreas digestion what was demon-
strated in animal model of pancreatic isolation (16). Indeed
this is the only class whose index values within the enzyme
blend directly correlates with the number of isolated islets.
Thus, CII is associated also with the decision as to whether or
not to transplant a preparation or not. This was quite an un-
expected result, because of the limited range of variability
(28–35%) between different batches, as previously reported
(3). Considering the direct correlation between NE and the
CII proportion in a vial, it would be expected that the highest
peak D (Index value)
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FIGURE 3. Correlation between D indexes of different
Liberase™ batches and the number of equivalent islets
(NE) (a) and correlation between B indexes and islet purity
(b) of the corresponding isolations in which these enzymes
were used. (c) Represents the comparison between D in-
dexes of enzyme of successful vs. failed isolation. Black bar
indicates the mean of D index values.
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peak D index
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FIGURE 4. Correlation between peak indexes and the
decision of transplanting islet preparation. Correlation
between D (a), B (b), and G (c) indexes obtained by mi-
croelectrophoresis analysis and the number of equiva-
lent islets (NE) of the corresponding isolations in which
these enzymes were used. Black squares indicate trans-
planted preparations, white squares indicate not trans-
planted preparations.
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islet yield as well as the highest number of transplanted prep-
arations would be obtained with the highest CII values. From
Figure 3 and Figure 4, it appears that this does not apply as the
best results in terms of transplant occur with 0.294–0.315CII
index values, a very narrow range.
The purified CII fraction collagenase shows some pro-
tein components present in small amounts (about 20% of
enzyme blend), and absent in CI fraction collagenase. The
presence of these proteins is inversely correlated with the
presence of CII collagenase (P0.001, r0.656), which
suggests that they may result from its degradation. The pro-
portion of fragments seems to have a negative role in the
isolation process (although the results are not statistically sig-
nificant) thus suggesting that the quality and the purity of CII
collagenase should be further improved.
It is clear that the success of isolation with regard to
number of isolated islets depends on many variables, includ-
ing donor characteristics and isolation procedures (4). There-
fore one component of enzyme should not determine per se
the fate of isolation. This appears also by the low value
(r0.305), albeit statistically significant, of the correlation
between collagenase class II index and number of isolated
islets in our retrospective analysis. Correct analyses of an
eventual association between variables of isolation should be
multivariate in a large number of cases, and this was not the
case of this study, conducted on 163 isolations. In a recent
retrospective multivariate analysis on 32 variables conducted
on more than 400 isolations, we demonstrated that the colla-
genase activity, normalized to the amount of the enzyme used
in the isolation (total activity), is one of the most important
variables associated with the number of islets obtained (4).
CII proportion similarly normalized to the milligram of en-
zyme used in each isolation, strictly correlated with the total
activity with r0.796. Therefore, these two parameters ap-
pear concordant, allowing us to hypothesize that the relation
between CII enzyme and the number of isolated islets ob-
served may be significant also in a multivariate analysis on a
large number of isolations although, of course, this should be
further confirmed.
The increased islet yield and purity achieved with an
optimal collagenase blend could be of relatively minor rele-
vance if associated with a reduced islet function or survival.
No correlation was observed between enzyme characteristics
and islet viability and insulin secretion, but the large data
dispersion at this regard and the poor number of cases avail-
able for this statistics limited the value of the analyses. We
used 2 additional indirect parameters for evaluation of the
quality of isolated islets: the suitability of an islet preparation
for transplantation and in vivo graft function. Islet prepara-
tion is usually defined transplantable if it is adequate in terms
of islet mass, viability and purity. Therefore, it should be con-
sidered per se an overall indirect parameter of the quality, and
this parameter was associated with high CII index values, too.
In vivo graft function should be not recognized as an ap-
propriate parameter for our study, being that in vivo graft
function involves too many variables, although—also in
this case—a significant correlation was observed between
CII and early graft function. At this regard, we do not
believe CII can directly affect in vivo graft function, or at
least the role of CII in affecting graft function should be
secondary to the larger transplanted islet mass made avail-
able using a successful enzyme.
CI collagenase, another essential component of a blend
enzyme designated to digest human pancreas, increases di-
gestion rate as reported (16). In our blend enzyme for islet
isolation we identified two different components of CI colla-
genase (designated as peak B and G), which are inversely cor-
related. Although neither of these correlates with the number
of isolated islets, peak B correlates directly with the purity of
the preparation. It was already reported that enzymes used for
pancreas digestion affected islet purification (21–22). Mech-
anisms should include the duration of digestion (and there-
fore of warm ischemia cell exposure), cell death, incomplete
tissue digestion that collectively could contribute to exocrine
cell degranulation and damage resulting in variable purifica-
tion of islet preparation.However, the best results concerning
the number of isolated islets and suitability of the preparation
for transplant are obtained fromamixture of CI components.
From this point of view, our conclusion differs from that
reported by Lakey on the analysis of Liberase™batch by high-
performance liquid chromatography (3, 25). In fact, Lakey
describes two components of CI collagenase, of which only
one was associated (in a small number of cases) with isolation
success (3). It should be noted that Lakey et al. had the pos-
sibility of using batch enzymes containing only one compo-
nent of class I collagenase (3, 22). We expect in the future to
test batches with similar characteristics in our laboratory.
From our analyses, it appeared that the small differ-
ences in neutral proteases content between different Liberase
batches failed to significantly affect pancreas digestion out-
come, differently from what it was recently reported (25).
These enzymes are considered important in the early steps of
digestion (21) and the composition and content of neutral
protease present in our Liberase batches appeared to be ade-
quate for a successful digestion. Further studies should also be
necessary to fully analyze the molecular structure of these
enzymes.
We confirmed differences between vials as reported by
Lakey, although to a lesser extent (3). In this regard, we did
not consider mass and enzyme activity changes in each vial,
thus probably underestimating the real variability among vi-
als. The microelectrophoresis analysis appears simple and re-
producible and could therefore be applied to a selection of
successful batches for the isolation. In fact, compared with
high-performance liquid chromatography, it is quicker, de-
scribing enzymatic blend composition in few minutes.
In conclusion, the significance of this study lies in the
fact that it represents the characterization of the components
of blended enzymes designated for human isolations. This
represents a first step toward the production of enzymes us-
ing recombinant techniques, the only means of guaranteeing
continuous and reproducible isolation results. In addition the
standardization of enzymes for digestion of human pancreas
should promote the digestion success rate of other tissue.
However, a more standardized production (3) capable of
guaranteeing the stability and reproducibility of the enzyme
for isolation purpose is now needed.
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